BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24398543)

  • 1. Peritoneal carcinomatosis in t4 colorectal cancer: occurrence and risk factors.
    van Santvoort HC; Braam HJ; Spekreijse KR; Koning NR; de Bruin PC; de Vries Reilingh TS; Boerma D; Smits AB; Wiezer MJ; van Ramshorst B
    Ann Surg Oncol; 2014 May; 21(5):1686-91. PubMed ID: 24398543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
    van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
    Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis.
    Klaver YL; Lemmens VE; de Hingh IH
    Eur J Surg Oncol; 2013 Jul; 39(7):734-41. PubMed ID: 23523316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
    Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
    Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
    Allard MA; Adam R; Ruiz A; Vibert E; Paule B; Levi F; Sebagh M; Guettier C; Azoulay D; Castaing D
    Eur J Surg Oncol; 2013 Sep; 39(9):981-7. PubMed ID: 23845705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and prognosis of synchronous colorectal carcinomatosis.
    Goéré D; Allard MA; Honoré C; Dumont F; Elias D
    Future Oncol; 2013 Apr; 9(4):541-9. PubMed ID: 23560376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
    Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
    Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of a macroscopically complete resection of colorectal cancer with peritoneal carcinomatosis.
    Matsuda K; Hotta T; Takifuji K; Yamamoto M; Nasu T; Togo N; Oka M; Tabuse K; Yamaue H
    Surgery; 2012 Feb; 151(2):238-44. PubMed ID: 21176934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
    Cashin PH; Graf W; Nygren P; Mahteme H
    Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma.
    Chua TC; Pelz JO; Kerscher A; Morris DL; Esquivel J
    Ann Surg Oncol; 2009 Oct; 16(10):2765-70. PubMed ID: 19641972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer.
    Segelman J; Granath F; Holm T; Machado M; Mahteme H; Martling A
    Br J Surg; 2012 May; 99(5):699-705. PubMed ID: 22287157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.
    Quere P; Facy O; Manfredi S; Jooste V; Faivre J; Lepage C; Bouvier AM
    Dis Colon Rectum; 2015 Aug; 58(8):743-52. PubMed ID: 26163953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis.
    Klaver YL; Chua TC; de Hingh IH; Morris DL
    J Surg Oncol; 2012 Feb; 105(2):113-8. PubMed ID: 21780124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytoreductive surgery alone for the treatment of peritoneal carcinomatosis of colorectal origin. A retrospective analysis with regard to multimodal treatments.
    Scaringi S; Leo F; Canonico G; Batignani G; Ficari F; Tonelli F
    Hepatogastroenterology; 2009; 56(91-92):650-5. PubMed ID: 19621673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis.
    Elias D; Goéré D; Di Pietrantonio D; Boige V; Malka D; Kohneh-Shahri N; Dromain C; Ducreux M
    Ann Surg; 2008 Mar; 247(3):445-50. PubMed ID: 18376188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy.
    Klaver YL; Simkens LH; Lemmens VE; Koopman M; Teerenstra S; Bleichrodt RP; de Hingh IH; Punt CJ
    Eur J Surg Oncol; 2012 Jul; 38(7):617-23. PubMed ID: 22572106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin.
    Winer J; Zenati M; Ramalingam L; Jones H; Zureikat A; Holtzman M; Lee K; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
    Ann Surg Oncol; 2014 May; 21(5):1456-62. PubMed ID: 24201745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients].
    Bova R; Kamphues C; Neuhaus P; Puhl G
    Zentralbl Chir; 2014 Apr; 139(2):220-5. PubMed ID: 23846535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study.
    Maggiori L; Goéré D; Viana B; Tzanis D; Dumont F; Honoré C; Eveno C; Elias D
    Ann Surg; 2013 Jul; 258(1):116-21. PubMed ID: 23207243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.
    Teo MC; Tan GH; Tham CK; Lim C; Soo KC
    Ann Surg Oncol; 2013 Sep; 20(9):2968-74. PubMed ID: 23504144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.